Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Number of holders
-
10
-
Total 13F principal, excl. options
-
229,579,000
-
Principal change
-
0
-
Total reported value, excl. options
-
$99,032,996
-
Value change
-
+$6,536
-
Number of buys
-
3
-
Number of sells
-
-3
-
Price
-
$0.4196
Significant Holders of CARDLYTICS INC - NOTE 1.000% 9/1 as of Q1 2023
11 filings reported holding 14161WAB1 - CARDLYTICS INC - NOTE 1.000% 9/1 as of Q1 2023.
CARDLYTICS INC - NOTE 1.000% 9/1 has 10 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $229,579,000 of principal
.
Largest 10 bondholders include CITADEL ADVISORS LLC ($88,700,000 of principal), Linden Advisors LP ($58,112,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($33,928,000 of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($20,160,000 of principal), 683 Capital Management, LLC ($11,025,000 of principal), Royal Bank of Canada ($10,386,000 of principal), GABELLI FUNDS LLC ($4,560,000 of principal), WELLINGTON MANAGEMENT GROUP LLP ($1,628,000 of principal), Teton Advisors, Inc. ($780,000 of principal), and GAMCO INVESTORS, INC. ET AL ($300,000 of principal).
This table shows the top 10 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.